Nicole Wong Doo

Dr. Nicole Wong Doo is a Senior Staff Specialist Haematologist and Senior Lecturer at Concord Clinical School within the Faculty of Medicine and Health at the University of Sydney. She serves as Director of the Haematology Clinical Research Unit at Concord Repatriation General Hospital and holds an Honorary Research Associate position at Cancer Council Victoria. In 2023, she was appointed as NSW Councillor of the Haematology Society of Australia and New Zealand, reflecting her leadership in the field.

Her educational background includes an MBBS (Hons), PhD in lymphoma and myeloma epigenetics from the University of Melbourne, FRACP, FRCPA, and a Graduate Certificate in Clinical Teaching. Her academic journey demonstrates a strong foundation in both clinical medicine and research methodology.

Dr. Wong Doo's research focuses on advancing treatments for hematologic malignancies through clinical trials and translational research. She leads a team of 20 in the Haematology Clinical Research Unit, integrating clinical trials within routine patient care. Her primary research interests include lymphoma (particularly Hodgkin lymphoma) and multiple myeloma clinical trials, supportive care, and patient-reported outcomes (PRO) research. She is the Australian principal investigator for the ALLG HD13 RADAR trial in Hodgkin lymphoma supported by MRFF and leads initiatives such as the MyHodgkin MyHealth mobile app for patient-entered health outcomes. Her work bridges laboratory discoveries with clinical applications to improve patient care.

Analysis of her publication record reveals a consistent focus on hematologic malignancies with particular emphasis on Hodgkin lymphoma and multiple myeloma. Her research spans clinical trials, epidemiological studies, treatment protocols, risk factor analysis, and innovative patient outcome measurement tools. The publications demonstrate strong international collaboration and multidisciplinary approaches to hematologic cancer research.

Dr. Wong Doo holds significant leadership positions including membership in the ALLG Multiple Myeloma, Lymphoma and Supportive Care Scientific Working Parties, the Australasian Lymphoma Alliance, and the Steering Committee of the Australasian Myeloma Research Consortium. She serves on the Royal College of Pathologists Australasia Pathology Education Outreach Committee, promoting hematology education across the Asia-Pacific region.

As Director of the Haematology Clinical Research Unit, she oversees numerous active clinical trials including the ALLG-HD11 phase III study, ISB-2001 phase I study in multiple myeloma, AMaRC-IBIS collaborative study, and the ALLG HD13 RADAR International collaborative study where she serves as country principal investigator. Her research program demonstrates substantial grant funding and institutional support for advancing hematology care.

Dr. Wong Doo maintains active involvement with key professional organizations including the Haematology Society of Australia and New Zealand, Royal Australasian College of Physicians, Royal College of Pathologists Australasia, and Australasian Leukaemia and Lymphoma Group, contributing to the broader hematology community through committee work and scientific leadership.